Stephens Inc. AR reduced its position in Hill-Rom Holdings Inc (NYSE:HRC) by 0.2% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 19,611 shares of the medical technology company’s stock after selling 48 shares during the period. Stephens Inc. AR’s holdings in Hill-Rom Holdings were worth $1,561,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in Hill-Rom Holdings by 17.5% in the 1st quarter. Vanguard Group Inc. now owns 5,737,481 shares of the medical technology company’s stock worth $405,066,000 after acquiring an additional 853,385 shares during the period. BlackRock Inc. grew its stake in Hill-Rom Holdings by 13,535.4% in the 1st quarter. BlackRock Inc. now owns 5,067,064 shares of the medical technology company’s stock worth $357,736,000 after acquiring an additional 5,029,903 shares during the period. State Street Corp grew its stake in Hill-Rom Holdings by 3.4% in the 1st quarter. State Street Corp now owns 1,637,462 shares of the medical technology company’s stock worth $115,603,000 after acquiring an additional 53,082 shares during the period. Neuberger Berman Group LLC grew its stake in Hill-Rom Holdings by 15.6% in the 1st quarter. Neuberger Berman Group LLC now owns 1,480,242 shares of the medical technology company’s stock worth $104,505,000 after acquiring an additional 199,901 shares during the period. Finally, Bank of New York Mellon Corp grew its stake in Hill-Rom Holdings by 53.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,235,608 shares of the medical technology company’s stock worth $98,367,000 after acquiring an additional 427,888 shares during the period. 82.31% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Hill-Rom Holdings Inc (HRC) Holdings Reduced by Stephens Inc. AR” was published by Daily Political and is the property of of Daily Political. If you are accessing this article on another website, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/09/15/hill-rom-holdings-inc-hrc-holdings-reduced-by-stephens-inc-ar.html.

Shares of Hill-Rom Holdings Inc (HRC) opened at 77.01 on Friday. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The stock’s 50 day moving average is $75.42 and its 200 day moving average is $75.05. The stock has a market capitalization of $5.07 billion, a PE ratio of 44.88 and a beta of 1.21.

Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings results on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.01. The business had revenue of $689.10 million during the quarter, compared to the consensus estimate of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The firm’s quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.81 EPS. Analysts anticipate that Hill-Rom Holdings Inc will post $3.82 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be given a $0.18 dividend. The ex-dividend date is Thursday, September 14th. This represents a $0.72 annualized dividend and a dividend yield of 0.93%. Hill-Rom Holdings’s dividend payout ratio (DPR) is presently 41.62%.

Several analysts have commented on HRC shares. Zacks Investment Research cut shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Thursday, May 25th. ValuEngine raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Barclays PLC lifted their target price on shares of Hill-Rom Holdings from $80.00 to $86.00 and gave the stock an “overweight” rating in a research note on Friday, June 9th. Cantor Fitzgerald started coverage on shares of Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “neutral” rating and a $86.00 target price for the company. Finally, Needham & Company LLC started coverage on shares of Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “buy” rating and a $95.00 target price for the company. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Hill-Rom Holdings presently has a consensus rating of “Buy” and an average price target of $88.17.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.